324 related articles for article (PubMed ID: 26776754)
1. Using physiologically based pharmacokinetic modeling and benchmark dose methods to derive an occupational exposure limit for N-methylpyrrolidone.
Poet TS; Schlosser PM; Rodriguez CE; Parod RJ; Rodwell DE; Kirman CR
Regul Toxicol Pharmacol; 2016 Apr; 76():102-12. PubMed ID: 26776754
[TBL] [Abstract][Full Text] [Related]
2. Quantitative risk analysis for N-methyl pyrrolidone using physiologically based pharmacokinetic and benchmark dose modeling.
Poet TS; Kirman CR; Bader M; van Thriel C; Gargas ML; Hinderliter PM
Toxicol Sci; 2010 Feb; 113(2):468-82. PubMed ID: 19875680
[TBL] [Abstract][Full Text] [Related]
3. Application of PBPK modeling in support of the derivation of toxicity reference values for 1,1,1-trichloroethane.
Lu Y; Rieth S; Lohitnavy M; Dennison J; El-Masri H; Barton HA; Bruckner J; Yang RS
Regul Toxicol Pharmacol; 2008 Mar; 50(2):249-60. PubMed ID: 18226845
[TBL] [Abstract][Full Text] [Related]
4. Derivation of an occupational exposure limit for an inhalation analgesic methoxyflurane (Penthrox(®)).
Frangos J; Mikkonen A; Down C
Regul Toxicol Pharmacol; 2016 Oct; 80():210-25. PubMed ID: 27181451
[TBL] [Abstract][Full Text] [Related]
5. Comparative developmental toxicities of the three major metabolites of N-methyl-2-pyrrolidone after oral administration in rats.
Saillenfait AM; Sabaté JP; Gallissot F
J Appl Toxicol; 2007; 27(6):571-81. PubMed ID: 17370238
[TBL] [Abstract][Full Text] [Related]
6. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
[TBL] [Abstract][Full Text] [Related]
7. Derivation of a chronic reference concentration for decalin.
Stuchal LD; Weil RE; Roberts SM
Regul Toxicol Pharmacol; 2013 Jun; 66(1):38-46. PubMed ID: 23454102
[TBL] [Abstract][Full Text] [Related]
8. Development of an occupational exposure limit for n-propylbromide using benchmark dose methods.
Stelljes ME; Wood RR
Regul Toxicol Pharmacol; 2004 Oct; 40(2):136-50. PubMed ID: 15450717
[TBL] [Abstract][Full Text] [Related]
9. Developmental toxicity of N-methyl-2-pyrrolidone in rats following inhalation exposure.
Saillenfait AM; Gallissot F; Morel G
Food Chem Toxicol; 2003 Apr; 41(4):583-8. PubMed ID: 12615131
[TBL] [Abstract][Full Text] [Related]
10. Proposed occupational exposure limits for select ethylene glycol ethers using PBPK models and Monte Carlo simulations.
Sweeney LM; Tyler TR; Kirman CR; Corley RA; Reitz RH; Paustenbach DJ; Holson JF; Whorton MD; Thompson KM; Gargas ML
Toxicol Sci; 2001 Jul; 62(1):124-39. PubMed ID: 11399800
[TBL] [Abstract][Full Text] [Related]
11. Application of a physiologically based pharmacokinetic model for reference dose and reference concentration estimation for acetone.
Gentry PR; Covington TR; Clewell HJ; Anderson ME
J Toxicol Environ Health A; 2003 Dec; 66(23):2209-25. PubMed ID: 14612334
[TBL] [Abstract][Full Text] [Related]
12. Derivation of an occupational exposure limit for diacetyl using dose-response data from a chronic animal inhalation exposure study.
Beckett EM; Cyrs WD; Abelmann A; Monnot AD; Gaffney SH; Finley BL
J Appl Toxicol; 2019 May; 39(5):688-701. PubMed ID: 30620996
[TBL] [Abstract][Full Text] [Related]
13. Developmental and reproductive toxicity evaluation of toluene vapor in the rat II. Developmental toxicity.
Roberts LG; Nicolich MJ; Schreiner CA
Reprod Toxicol; 2007 Jun; 23(4):521-31. PubMed ID: 17360154
[TBL] [Abstract][Full Text] [Related]
14. Teratogenicity study of N-methylpyrrolidone after dermal application to Sprague-Dawley rats.
Becci PJ; Knickerbocker MJ; Reagan EL; Parent RA; Burnette LW
Fundam Appl Toxicol; 1982; 2(2):73-6. PubMed ID: 7185604
[TBL] [Abstract][Full Text] [Related]
15. Principles of risk assessment for determining the safety of chemicals: recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate.
Hasegawa R; Koizumi M; Hirose A
Congenit Anom (Kyoto); 2004 Jun; 44(2):51-9. PubMed ID: 15198717
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of N-methyl-2-pyrrolidone (NMP) and its metabolites in plasma and urine following oral administration of NMP to rats.
Carnerup MA; Saillenfait AM; Jönsson BA
Food Chem Toxicol; 2005 Sep; 43(9):1441-7. PubMed ID: 15951091
[TBL] [Abstract][Full Text] [Related]
17. Workplace environmental exposure level guide: n-Methyl-2-pyrrolidone.
Toxicol Ind Health; 2022 Jun; 38(6):309-329. PubMed ID: 35658636
[TBL] [Abstract][Full Text] [Related]
18. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
Kirman CR; Sweeney LM; Corley R; Gargas ML
Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
[TBL] [Abstract][Full Text] [Related]
19. Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration.
Willhite CC; Ball GL; McLellan CJ
J Toxicol Environ Health B Crit Rev; 2008 Feb; 11(2):69-146. PubMed ID: 18188738
[TBL] [Abstract][Full Text] [Related]
20. Cancer dose--response assessment for acrylonitrile based upon rodent brain tumor incidence: use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity.
Kirman CR; Gargas ML; Marsh GM; Strother DE; Klaunig JE; Collins JJ; Deskin R
Regul Toxicol Pharmacol; 2005 Oct; 43(1):85-103. PubMed ID: 16099568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
